Canakinumab is a powerful immunomodulator medicine, available as a subcutaneous injection under the brand name Ilaris, used to treat rare autoinflammatory uveitis conditions.
| Drug class | Biologic (Anti-IL1) |
|---|---|
| Type | Single |
| Forms | Subcutaneous Injection |
| Common strength | 150 mg |
| Common Indian brands | Ilaris |
| Prescription status | Prescription |
What Canakinumab is used for
Canakinumab (brand name Ilaris) is a specialized medicine used to treat certain rare and severe eye conditions known as autoinflammatory uveitis. Uveitis is an inflammation of the uvea, the middle layer of your eye, which can cause redness, pain, blurred vision, and sensitivity to light. When uveitis is ‘autoinflammatory’, it means your body’s own immune system mistakenly attacks healthy tissues, causing inflammation. Canakinumab helps to control this inflammation.
Specifically, it is used for conditions such as:
- CAPS (Cryopyrin-Associated Periodic Syndromes), which are a group of rare genetic autoinflammatory diseases.
- Behcet’s disease, a rare disorder that causes inflammation in blood vessels throughout the body, including the eyes.
These conditions are serious and require careful management by specialists to protect your vision and overall health.
How it works
Canakinumab is an immunomodulator, which means it works by adjusting or ‘modulating’ your immune system. More specifically, it is a ‘biologic’ medicine that targets a specific part of your immune system. It works by blocking a protein called interleukin-1 beta (IL-1 beta).
In autoinflammatory conditions like those treated by Canakinumab, IL-1 beta plays a key role in causing inflammation. By blocking IL-1 beta, Canakinumab helps to reduce the inflammation in your eyes and other parts of your body. This helps to control the symptoms of your condition and prevent further damage. It is a long-acting medicine, which means its effects last for an extended period after each dose.
How it’s used
Canakinumab is administered as a subcutaneous injection, which means it is given just under the skin. This medicine is available in a strength of 150 mg.
The typical dosing schedule for Canakinumab is once every 8 weeks. However, the exact dose and frequency will be determined by your ophthalmologist or specialist, based on your specific condition and how you respond to the treatment. It is crucial to follow their instructions precisely.
Since this is a powerful medicine, it will always be administered under the guidance and supervision of a specialist. They will provide detailed instructions on how and where the injection should be given, or it may be administered by a healthcare professional at the hospital or clinic.
Always follow your ophthalmologist’s exact instructions.
Brands available in India
- Ilaris
Brand availability and pricing vary; confirm with your pharmacist.
Please note
Powerful medicine that suppresses the immune system. Screening for tuberculosis and hepatitis is usually required before starting, and it raises the risk of infection. Used only under specialist supervision with regular monitoring.
Precautions & side effects
Canakinumab is a powerful medicine that requires careful consideration and monitoring. Here are some important precautions and warnings:
- Specialist Use: This medicine is only used under the supervision of a specialist doctor, such as an ophthalmologist specializing in uveitis or a rheumatologist. They will carefully assess if this treatment is suitable for you.
- High Cost: Canakinumab is a high-cost medicine, and your doctor will discuss the financial implications with you.
- Immune System Suppression: Canakinumab suppresses your immune system. While this helps reduce inflammation, it also means your body’s ability to fight off infections is lowered.
- Infection Risk: Due to immune suppression, there is an increased risk of developing infections. You must report any signs of infection (like fever, chills, sore throat, cough, unusual tiredness, or skin sores) to your doctor immediately.
- Screening Required: Before starting Canakinumab, your doctor will usually require screening tests for tuberculosis (TB) and hepatitis. This is because suppressing the immune system can reactivate latent (hidden) infections.
- Regular Monitoring: You will need regular monitoring by your specialist while on this medication to check for side effects and assess the effectiveness of the treatment.
- Prescription Only: Canakinumab is a prescription-only medicine and cannot be obtained without a valid prescription from a qualified doctor.
Understanding Uveitis and Autoinflammatory Conditions
Uveitis is a serious eye condition that involves inflammation of the uvea, the middle layer of your eye. The uvea contains many blood vessels and is crucial for your eye’s health and vision. When it becomes inflamed, it can lead to symptoms like redness, pain, sensitivity to light (photophobia), and blurred vision. If left untreated, severe or chronic uveitis can cause complications such as glaucoma, cataracts, and even permanent vision loss.
In some cases, uveitis is ‘autoinflammatory’. This means that your body’s immune system, which normally protects you from germs and diseases, mistakenly attacks your own healthy tissues, causing inflammation. Unlike autoimmune diseases, autoinflammatory conditions often involve a more direct, rapid inflammatory response. Conditions like CAPS (Cryopyrin-Associated Periodic Syndromes) and Behcet’s disease are examples where the immune system’s overactivity leads to persistent inflammation, including in the eyes. Medicines like Canakinumab are designed to specifically target and calm this overactive immune response, helping to control the inflammation and protect your vision.
General Advice for Managing Your Eye Health
Taking care of your eyes, especially when dealing with a condition like uveitis, is very important. Always follow your doctor’s instructions regarding your medication, including Canakinumab. Do not stop or change your dose without consulting your specialist. Regular follow-up appointments are crucial to monitor your condition and the effectiveness of your treatment. If you are receiving injections, ensure you understand the process and any after-care instructions. Maintain good personal hygiene, especially hand hygiene, to minimize the risk of infections, which is particularly important when on immune-suppressing medication. Avoid rubbing your eyes, as this can irritate them and potentially introduce germs.
Pay attention to any changes in your vision or new symptoms. If you experience increased eye pain, redness, sudden blurring of vision, flashes of light, floaters, or any signs of infection (like fever, chills, or unusual tiredness), contact your doctor immediately. It’s also wise to inform all your healthcare providers (including your dentist) that you are on an immune-suppressing medication like Canakinumab. Living with a chronic eye condition can be challenging, so don’t hesitate to seek support from family, friends, or patient support groups if needed. Maintaining a healthy lifestyle, including a balanced diet and adequate rest, can also contribute to your overall well-being.
Storing Your Medication and General Hygiene
Proper storage of your medication is essential to ensure its effectiveness. While Canakinumab is typically administered by a healthcare professional, if you are given any part of the medication to store at home, always follow the specific storage instructions provided by your doctor or pharmacist. Generally, biologic medicines like Canakinumab need to be stored in a refrigerator, protected from light, and not frozen. Never use medication that has expired or has been stored improperly. Keep all medicines out of the reach and sight of children.
Good hygiene practices are vital, especially when your immune system is suppressed. Always wash your hands thoroughly with soap and water before and after handling any medication or touching your eyes. Avoid sharing personal items like towels or eye makeup, as this can spread infections. If you wear contact lenses, discuss with your doctor whether it’s safe to continue wearing them during treatment, as they might increase the risk of infection or irritation. Maintaining a clean living environment can also help reduce your exposure to germs. Your healthcare team will provide specific advice tailored to your situation, so always feel free to ask them any questions you may have about hygiene and medication storage.
Frequently asked questions
What is Canakinumab used for?
Canakinumab is used to treat rare autoinflammatory uveitis conditions, such as CAPS (Cryopyrin-Associated Periodic Syndromes) and Behcet's disease, which cause inflammation in the eyes.
How does Canakinumab work?
Canakinumab is an immunomodulator that works by blocking a specific protein called interleukin-1 beta (IL-1 beta). By blocking IL-1 beta, it helps to reduce the inflammation caused by your body's overactive immune system in autoinflammatory conditions.
What are the common Indian brands for Canakinumab?
In India, Canakinumab is available under the brand name Ilaris.
How is Canakinumab administered and how often?
Canakinumab is given as a subcutaneous injection (under the skin) at a strength of 150 mg. It is typically administered every 8 weeks, but your specialist will determine the exact schedule.
Do I need a prescription for Canakinumab?
Yes, Canakinumab is a powerful medicine and requires a valid prescription from a qualified specialist doctor.
What are the key precautions I should be aware of when taking Canakinumab?
Canakinumab is a powerful medicine that suppresses the immune system, increasing the risk of infection. You will usually need screening for tuberculosis and hepatitis before starting. It is also a high-cost medicine and must only be used under specialist supervision with regular monitoring.
References
- Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database – PMC
- Eye health – MedlinePlus (US National Library of Medicine)
- Eye health information – American Academy of Ophthalmology
- Learn about eye health – National Eye Institute (NIH)
- Blindness and vision impairment – World Health Organization
Medically reviewed by Dr. C Jagadesh Reddy, Chief Surgeon: Cornea, Cataract and Refractive Surgery — last reviewed 2026-07-28.
This page is for general education only and is not a substitute for professional medical advice, diagnosis or treatment. Never self-medicate or reuse an old prescription. Always consult a qualified ophthalmologist before starting, changing or stopping any eye medicine.
